Lakhan.M.S
Hypersensitivity Reactions
Hypersensitivity
 Undesirable injurious consequences in the
sensitised host,following contact with specific
antigen.
 Generally the immune system is protective
 Protective mechanisms may result in severe
damages to tissues and may lead to death
 Severe damages may occur when the
immune system respond in exaggerated or
inappropriate form.
 Sensitising dose or Priming dose.
Initial contact with antigen-
sensitises Immune system-B & T
lymphocytes.
 Shocking dose
Subsequent contact with same
antigen-
HYPERSENSITIVITY REACTIONS.
Type of reaction Clinical Syndrome Mediators
Type I (IgE type) 1.Anaphylaxis
2.Atopy
IgE,histamine
Type 2 (Cytolytic &
Cytotoxic)
1.Thrombocytopeni
a
2.Agranulocytosis
3.Haemolytic
Anaemia
IgG IgM
Type 3 (Immune
Complex)
1.Arthus reaction
2.Serum Sickness
IgG IgM
Type 4 (Delayed type) 1.Tuberculin.
2.Contact
Dermatitis.
T cells
Type I Reactions
 SENSITISED INDIVIDUALS- antibodies are fixed
on surface of tissue cells-Mast cells & Basophils.
 On subsequent exposure
Antigen combines with cell fixed
antibody- release of Pharmacologically Active
Substances.
HYPERSENSITIVITY REACTIONS
 Two forms
 ANAPHYLAXIS –acute,fatal & systemic
 ATOPY – recurrent,non-fatal & localised
Exposure to allergen
Production of IgE Ab+
fix to mast cell
On Re-Exposure
Antigen-Antibody complex
on mast cell surface
Release Mediators Clinical manifestations of
anaphylaxis
Mediators
 Vasodilation and increased permeability
Histamine
Leukotriene
Prostaglandin
Neutral proteases
 Smooth muscle spasm
Histamine
Leukotriene
Prostaglandin
 Leukocyte extravasation
Cytokines (e.g. chemokines and TNF)
Leukotriene
Chemotactic factors for neutrophils and eosinophils
Type I – Examples
 Allergic asthma
 Allergic conjunctivitis
 Allergic rhinitis
 Angioedema
 Urticaria
ATOPY
 Familial,occurs spontaneously.
 Common antigens- Pollens,House dust & Food.
 Atopic individuals have higher levels of IgE and
eosinophils
 Mechanism of action- Similar to anaphylaxis but
reaction occurs at the site of entry and sensitising
dose not required.
Type I Hypersensitivity
 Prevention of type I hypersensitivity
 Identify and avoid allergens
 Identify food allergens by eliminating
suspected foods from diet
 Immunotherapy can help prevent allergic
reactions
 Administer a series of injections of dilute
allergen
 Must be repeated every two to three
years
Treatment of type I
hypersensitivity
 Administer drugs that counteract
inflammatory mediators
 Antihistamines neutralize histamine
 Treat asthma with a corticosteroid and a
bronchodilator
 Epinephrine neutralizes many
mechanisms of anaphylaxis
 Relaxes smooth muscle
 Reduces vascular permeability
 Severe asthma and anaphylactic shock
require emergency treatment
Treatment of Anaphylactic
Shock
1.Inj .Adrenaline (1:1000) 0.3-0.5 ml im.
2.Inj.Hydrocortisone 100-200 mg iv.
3.Inj.Pheniramine 45 mg im/iv.
4.IV fluids.
Type II Reactions
 Cytotoxic & Cytolitic
 Antibodies produced by the immune response
bind to antigens on the patient's own cell
surfaces.
 Causes
1.Phagocytosis of cell through opsonic
adherence.
2.Cytotoxicity by Natural Killer cells.
3.Lysis through activation of complement
system.
 Antigens can be
-Intrinsic ("self" antigen, innately part of patient's cells)
-Extrinsic (adsorbed onto the cells during exposure to foreign
antigen).
 These cells are recognized by macrophages or dendritic cells,
which act as antigen-presenting cells.
 This cause B cell response, where antibodies are produced
against foreign antigen
Examples
 Autoimmune Anaemia & Haemolytic disease of the
newborn.- Antierythrocyte antibody causes lysis of
red cells.
 Goodpasture's syndrome
Basement membrane(containing collagen type IV) in
the lung and kidney is attacked by our own antibodies
 Drug reactions-
Sedormid purpura
Other drugs Sulphonamides,Thiazide
diuretics,Quinidine also causes similar type of
purpura.
Other examples of Type II
 Pernicious anemia
 Immune thrombocytopenia
 Transfusion reactions
 Hashimoto's thyroiditis
Type III- Immune Complex Reactions
 Characterised by
1.Deposition of Antigen-Antibody complex in
tissue.
2. Activation of Complement
3.Infiltration of Polymorphonuclear leucocytes.
TISSUE DAMAGE
Antigen combines with Antibody
Producing Free floating Complex
Deposited in tissues
Immune-Complex Reactions
Type III
 Two types
-Arthus Reaction (Localised)
-Serum Sickness (Generalised)
Serum sickness- A single dose serves both as the
sensitising and shocking dose. –
Fever,Urticaria,Arthralgia,Lymphadenopathy,Sple
nomegaly.
Type III (Immune Complex–
Mediated) Hypersensitivity
 Caused by formation of immune complexes
 Can cause localized reactions
 Hypersensitivity pneumonitis
 Glomerulonephritis
 Hypersensitivity pneumonitis
 Inhalation of antigens into lungs stimulates
antibody production
 Subsequent inhalation of the same antigen
results in formation of immune complexes
 Activates complement
Type III (Immune Complex–
Mediated) Hypersensitivity
 Can cause systemic reactions
 Systemic lupus erythematosus
 Rheumatoid arthritis
Type IV Delayed or cell mediated
Reactions
 Mediated by sensitised T Lymphocytes
Contact with specific Antigen
Release Lymphokines
Effect on Macrophage,Leucocytes &
Tissue Cells.
 Occurs within 48-72 hours of antigen exposure.
Type IV Delayed or cell mediated
Reactions
 Two types
Tuberculin Type
Contact Dermatitis
Type IV
 The tuberculin response
 An injection of tuberculin beneath the skin
causes reaction in individual exposed to
tuberculosis or tuberculosis vaccine
 Used to diagnose contact with antigens of
M. tuberculosis
 No response when individual not
infected or vaccinated
 Red, hard swelling develops in
individuals previously infected or
immunized
Type V Stimulatory type
 Modification of Type II hypersensitivity reactions.
 Antigen-Antibody reaction enhances the activity
of affected cells- cell proliferation &
differentiation,instead of inhibition or killing.
Example
-Graves disease
presence of Long Acting Thyroid Stimulating
Antibody
-Mysthaenia Gravis
 Thank You

Hypersensitivity reactions

  • 1.
  • 2.
    Hypersensitivity  Undesirable injuriousconsequences in the sensitised host,following contact with specific antigen.  Generally the immune system is protective  Protective mechanisms may result in severe damages to tissues and may lead to death  Severe damages may occur when the immune system respond in exaggerated or inappropriate form.
  • 3.
     Sensitising doseor Priming dose. Initial contact with antigen- sensitises Immune system-B & T lymphocytes.  Shocking dose Subsequent contact with same antigen- HYPERSENSITIVITY REACTIONS.
  • 4.
    Type of reactionClinical Syndrome Mediators Type I (IgE type) 1.Anaphylaxis 2.Atopy IgE,histamine Type 2 (Cytolytic & Cytotoxic) 1.Thrombocytopeni a 2.Agranulocytosis 3.Haemolytic Anaemia IgG IgM Type 3 (Immune Complex) 1.Arthus reaction 2.Serum Sickness IgG IgM Type 4 (Delayed type) 1.Tuberculin. 2.Contact Dermatitis. T cells
  • 5.
    Type I Reactions SENSITISED INDIVIDUALS- antibodies are fixed on surface of tissue cells-Mast cells & Basophils.  On subsequent exposure Antigen combines with cell fixed antibody- release of Pharmacologically Active Substances. HYPERSENSITIVITY REACTIONS
  • 6.
     Two forms ANAPHYLAXIS –acute,fatal & systemic  ATOPY – recurrent,non-fatal & localised
  • 7.
    Exposure to allergen Productionof IgE Ab+ fix to mast cell On Re-Exposure Antigen-Antibody complex on mast cell surface Release Mediators Clinical manifestations of anaphylaxis
  • 8.
    Mediators  Vasodilation andincreased permeability Histamine Leukotriene Prostaglandin Neutral proteases  Smooth muscle spasm Histamine Leukotriene Prostaglandin  Leukocyte extravasation Cytokines (e.g. chemokines and TNF) Leukotriene Chemotactic factors for neutrophils and eosinophils
  • 9.
    Type I –Examples  Allergic asthma  Allergic conjunctivitis  Allergic rhinitis  Angioedema  Urticaria
  • 10.
    ATOPY  Familial,occurs spontaneously. Common antigens- Pollens,House dust & Food.  Atopic individuals have higher levels of IgE and eosinophils  Mechanism of action- Similar to anaphylaxis but reaction occurs at the site of entry and sensitising dose not required.
  • 11.
    Type I Hypersensitivity Prevention of type I hypersensitivity  Identify and avoid allergens  Identify food allergens by eliminating suspected foods from diet  Immunotherapy can help prevent allergic reactions  Administer a series of injections of dilute allergen  Must be repeated every two to three years
  • 12.
    Treatment of typeI hypersensitivity  Administer drugs that counteract inflammatory mediators  Antihistamines neutralize histamine  Treat asthma with a corticosteroid and a bronchodilator  Epinephrine neutralizes many mechanisms of anaphylaxis  Relaxes smooth muscle  Reduces vascular permeability  Severe asthma and anaphylactic shock require emergency treatment
  • 13.
    Treatment of Anaphylactic Shock 1.Inj.Adrenaline (1:1000) 0.3-0.5 ml im. 2.Inj.Hydrocortisone 100-200 mg iv. 3.Inj.Pheniramine 45 mg im/iv. 4.IV fluids.
  • 14.
    Type II Reactions Cytotoxic & Cytolitic  Antibodies produced by the immune response bind to antigens on the patient's own cell surfaces.  Causes 1.Phagocytosis of cell through opsonic adherence. 2.Cytotoxicity by Natural Killer cells. 3.Lysis through activation of complement system.
  • 15.
     Antigens canbe -Intrinsic ("self" antigen, innately part of patient's cells) -Extrinsic (adsorbed onto the cells during exposure to foreign antigen).  These cells are recognized by macrophages or dendritic cells, which act as antigen-presenting cells.  This cause B cell response, where antibodies are produced against foreign antigen
  • 16.
    Examples  Autoimmune Anaemia& Haemolytic disease of the newborn.- Antierythrocyte antibody causes lysis of red cells.  Goodpasture's syndrome Basement membrane(containing collagen type IV) in the lung and kidney is attacked by our own antibodies  Drug reactions- Sedormid purpura Other drugs Sulphonamides,Thiazide diuretics,Quinidine also causes similar type of purpura.
  • 17.
    Other examples ofType II  Pernicious anemia  Immune thrombocytopenia  Transfusion reactions  Hashimoto's thyroiditis
  • 18.
    Type III- ImmuneComplex Reactions  Characterised by 1.Deposition of Antigen-Antibody complex in tissue. 2. Activation of Complement 3.Infiltration of Polymorphonuclear leucocytes. TISSUE DAMAGE Antigen combines with Antibody Producing Free floating Complex Deposited in tissues Immune-Complex Reactions
  • 19.
    Type III  Twotypes -Arthus Reaction (Localised) -Serum Sickness (Generalised) Serum sickness- A single dose serves both as the sensitising and shocking dose. – Fever,Urticaria,Arthralgia,Lymphadenopathy,Sple nomegaly.
  • 20.
    Type III (ImmuneComplex– Mediated) Hypersensitivity  Caused by formation of immune complexes  Can cause localized reactions  Hypersensitivity pneumonitis  Glomerulonephritis  Hypersensitivity pneumonitis  Inhalation of antigens into lungs stimulates antibody production  Subsequent inhalation of the same antigen results in formation of immune complexes  Activates complement
  • 21.
    Type III (ImmuneComplex– Mediated) Hypersensitivity  Can cause systemic reactions  Systemic lupus erythematosus  Rheumatoid arthritis
  • 22.
    Type IV Delayedor cell mediated Reactions  Mediated by sensitised T Lymphocytes Contact with specific Antigen Release Lymphokines Effect on Macrophage,Leucocytes & Tissue Cells.  Occurs within 48-72 hours of antigen exposure.
  • 23.
    Type IV Delayedor cell mediated Reactions  Two types Tuberculin Type Contact Dermatitis
  • 24.
    Type IV  Thetuberculin response  An injection of tuberculin beneath the skin causes reaction in individual exposed to tuberculosis or tuberculosis vaccine  Used to diagnose contact with antigens of M. tuberculosis  No response when individual not infected or vaccinated  Red, hard swelling develops in individuals previously infected or immunized
  • 26.
    Type V Stimulatorytype  Modification of Type II hypersensitivity reactions.  Antigen-Antibody reaction enhances the activity of affected cells- cell proliferation & differentiation,instead of inhibition or killing. Example -Graves disease presence of Long Acting Thyroid Stimulating Antibody -Mysthaenia Gravis
  • 28.